The concomitant occurrence of hidradenitis suppurativa and Fournier’s gangrene
  • Georges Khattar
    Department of Internal Medicine, Staten Island University Hospital/Northwell Health, New York, USA
  • Elie Bou Sanayeh
    Department of Internal Medicine, Staten Island University Hospital/Northwell Health, New York, USA
  • Marina Makram
    Touro College of Osteopathic Medicine, New York City, USA
  • Hussein Rabah
    Department of Sleep Medicine, Emory School of Medicine, Atlanta, USA
  • Saif Abu Baker
    Department of Internal Medicine, Staten Island University Hospital/Northwell Health, New York, USA
  • Salman Khan
    Department of Internal Medicine, Staten Island University Hospital/Northwell Health, New York, USA
  • Catherine Hong
    Department of Internal Medicine, Staten Island University Hospital/Northwell Health, New York, USA

Keywords

Fournier’s gangrene, hidradenitis suppurativa, septic shock, skin and soft tissue infection

Abstract

Background: Fournier’s gangrene represents a life-threatening necrotising infection affecting the perineal region, while hidradenitis suppurativa is characterised by a chronic inflammatory skin condition. The simultaneous occurrence of both conditions is exceedingly rare.
Case description: A 42-year-old female with a documented history of severe untreated hidradenitis suppurativa presented for shortness of breath, fever and lethargy, along with extensive wounds and skin breakdown involving the left axilla, perineum, lower back, lumbosacral region and bilateral gluteal areas, extending to the perineum. Upon presentation, the patient was in a state of septic shock, and a diagnosis of actively manifesting Fournier’s gangrene was established at the site of the pre-existing hidradenitis suppurativa lesions. Despite the implementation of an aggressive multidisciplinary approach incorporating surgical interventions, antibiotic therapy and intensive care measures, the patient’s condition deteriorated, culminating in septic shock, multi-organ failure and eventual demise. In this report, we discuss both clinical entities, their similarities and differences, and the possible mechanisms by which they may have co-occurred.
Conclusion: The co-existence of hidradenitis suppurativa and Fournier’s gangrene poses unique challenges, given the rapid progression of Fournier’s gangrene within the context of hidradenitis suppurativa, potentially suggesting the latter as a predisposing factor. This case underscores the importance of vigilant screening and management of hidradenitis suppurativa.

VIEW THE ENTIRE ARTICLE

References

  • li>Prens E, Deckers I. Pathophysiology of hidradenitis suppurativa: an update. J Am Acad Dermatol 2015;73:S8–S11.
  • Lewis GD, Majeed M, Olang CA, Patel A, Gorantla VR, Davis N, et al. Fournier’s gangrene diagnosis and treatment: a systematic review. Cureus 2021;13:e18948.
  • Magdaleno-Tapial J, Valenzuela-Oñate C, Martínez-Doménech A, Sánchez-Carazo JL, Pérez-Ferriols A. Image gallery: Fournier gangrene in a patient with severe hidradenitis suppurativa. Br J Dermatol 2019;181:e59.
  • Castillejo Becerra CM, Jaeger CD, Rose JR, Beecroft NJ, Shah NC, Posid T, et al. Microorganisms and antibiogram patterns in Fournier’s gangrene: contemporary experience from a single tertiary care center. J Urol 2020;204:1249–1255.
  • Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier’s gangrene. J Urol 1995;154:89–92.
  • Seyed Jafari SM, Hunger RE, Schlapbach C. Hidradenitis suppurativa: current understanding of pathogenic mechanisms and suggestion for treatment algorithm. Front Med (Lausanne) 2020;7:68.
  • Ballard K, Shuman VL. Hidradenitis suppurativa. 2023 Apr 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan.
  • Malik AM, Malik NH, Ahsan MR, Shakeel M, Chaudhry AM, Hamid MR. Fournier’s gangrene: an analysis of factors affecting mortality and morbidity. JAMC 2016;28:518–521.
  • Ro JY, Divatia MK, Kim K-R, Amin MB, Ayala AG. Penis and scrotum. In: Cheng L, MacLennan GT, Bostwick DG, editors. Urologic Surgical Pathology (fourth edition), Amsterdam: Elsevier; 2020 p. 853–901.
  • 10. Jemec GBE. Clinical Practice. Hidradenitis suppurativa. N Engl J Med 2012;366:158–164.
  • Melnik BC, John SM, Chen W, Plewig G. T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities. Br J Dermatol 2018;179:260–272.
  • Matusiak L, Bieniek A, Szepietowski JC. Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-alpha agents? Acta Derm Venereol 2009;89:601–603.
  • Delano MJ, Ward PA. The immune system’s role in sepsis progression, resolution, and long-term outcome. Immunol Rev 2016;274:330–353.
  • Views: 165
    HTML downloads: 8
    PDF downloads: 109


    Published: 2024-04-23
    Issue: 2024: Vol 11 No 6 (view)


    How to cite:
    1.
    Khattar G, Bou Sanayeh E, Makram M, Rabah H, Abu Baker S, Khan S, Hong C. The concomitant occurrence of hidradenitis suppurativa and Fournier’s gangrene. EJCRIM 2024;11 doi:10.12890/2024_004493.

    Most read articles by the same author(s)